You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 234 No. 2, October 13, 1975 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (27)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hypercalcitonemia in Bronchogenic Cancer

Evidence for Thyroid Origin of the Hormone

Omega L. Silva, MD; Kenneth L. Becker, MD, PhD; Aron Primack, MD; John L. Doppman, MD; Richard H. Snider, PhD

JAMA. 1975;234(2):183-185.


Abstract

Retrograde venous catheterization in a hypercalcitonemic patient with adenocarcinoma of the lung demonstrated that the thyroid gland was secreting a very large amount of hormone (14-fold higher than the peripheral level), while the venous drainage from the tumor deposits was similar in concentration to that of the periphery. Conceivably, the calcitonin is being elaborated in response to metastatic and humoral bone resorption or both. Radiotherapy resulted in a decrease in the calcitonin level. Further studies are needed to determine the diagnostic or prognostic implications of serum calcitonin in bronchogenic cancer.

(JAMA 234:183-185, 1975)



Author Affiliations

From the Metabolic Research Section (Drs Silva, Becker, and Snider) and the Medical Oncology Branch (Dr Primack), Veterans Administration Hospital, Washington, DC; Department of Medicine, George Washington University, Washington, DC (Drs Silva and Becker); and the Department of Diagnostic Radiology (Dr Doppman) and the National Cancer Institute (Dr Primack), National Institutes of Health, Bethesda, Md.


Footnotes

Reprint requests to Metabolic Research (151-J), Veterans Administration Hospital, 50 Irving St, NW, Washington, DC 20422 (Dr Silva).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Urine Calcitonin Levels in Patients With Bronchogenic Carcinoma
Becker et al.
JAMA 1980;243:670-672.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.